We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GCT:NASDAQGigaCloud Technology Inc Analysis

Data as of 2026-04-05 - not real-time

$44.78

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

GigaCloud Technology is trading comfortably above its short‑term moving averages, with a bullish MACD signal and a neutral RSI that suggests the stock is neither overbought nor oversold. The price sits on solid support near the low‑forties and faces resistance just below the high‑forties, establishing a clear trading range. Recent sessions have seen the stock outperform both the broader market and its sector, driven by strong revenue growth and a positive earnings beat, while an insider sale has been noted but has not dampened overall sentiment, which remains buoyant under an extreme‑greed market mood.
Fundamentally, the valuation appears attractive: the trailing P/E is well below the industry average and a discounted cash‑flow model points to a substantial upside potential. Margins are modest yet improving, and operating cash flow comfortably exceeds debt service requirements, although leverage is elevated. High volatility and a beta above market levels highlight sensitivity to broader swings, tempering the upside. Together, these dynamics make GCT a compelling candidate for investors seeking growth‑oriented, undervalued technology exposure.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Bullish MACD crossover reinforcing upward momentum
  • Price positioned above short‑term moving averages
  • Support level remaining intact

Medium Term

1–3 years
Positive
Model confidence: 9/10

Key Factors

  • Significant valuation gap to discounted cash‑flow estimate
  • Robust revenue growth outpacing peers
  • Trailing P/E substantially lower than industry average

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained expansion in B2B ecommerce niche
  • Operating cash flow comfortably covering debt obligations
  • Strategic positioning with cross‑border logistics advantage

Key Metrics & Analysis

Financial Health

Revenue Growth22.60%
Profit Margin10.65%
P/E Ratio12.5
ROE30.84%
ROA7.98%
Debt/Equity96.68
P/B Ratio3.4
Op. Cash Flow$190.7M
Free Cash Flow$132.4M
Industry P/E33.5

Technical Analysis

TrendBullish
RSI56.0
Support$39.44
Resistance$47.75
MA 20$42.98
MA 50$40.73
MA 200$32.62
MACDBullish
VolumeStable
Fear & Greed Index78.8

Valuation

Fair Value$119.54
Target Price$53.75
Upside/Downside20.03%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.67
Volatility102.38%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.